Home » Biotechnology » Veterinary Molecular Diagnostics Market Size, Share, Analysis Report
PCR kits segment dominates the market with a market value of US$ 63 Mn in 2017. The segment is expected to maintain its dominance over the forecast period with a market value of US$ 123.9 by 2027 end and expands at a significant CAGR. The potential for developing high specificity molecular diagnostic kits has been attained by initiating mass producing of molecular diagnostic kits for vast veterinary applications. Properly designed genetic assays, acceptable controls, and tough take a look at elucidation, are essential for getting accuracy and hyperbolic specificity altogether polymer based mostly molecular testing. Leading firms within the veterinary molecular medical specialty business are actively producing varied diagnostic kits and reagents to manage and stop animal diseases. However, bound manual handling errors touching clinical effectivity of molecular tests specificity and high prices of veterinary molecular kits and reagents limit the adoption of animal molecular testing over alternative diagnostic procedures like diagnostic imaging, immunodiagnostics, clinical chemistry and others.
Global Veterinary Molecular Diagnostics Market is segmented based on the product as, PCR kits, INAAT kits, Microarray kits and DNA sequencing kits. On the basis of disease type, the market has been segmented into Anaplasma spp., Ehrlichia spp., New Castle Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS) and others. Based on species type, the market has been segmented into livestock animals including Aquatic, Bovine, Porcine, Ovine, Poultry and Equine. The report segments global Veterinary Molecular Diagnostics Market based on end-use as hospitals, clinical laboratories and veterinary research institutes.
Global Veterinary Molecular Diagnostics Market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Veterinary Molecular Diagnostics Market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global Veterinary Molecular Diagnostics Market share consists of several players including IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID. Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.
Veterinary Molecular Diagnostics Market has been segmented as below:
Veterinary Molecular Diagnostics Market, By Product
Veterinary Molecular Diagnostics Market, By Disease Type
Veterinary Molecular Diagnostics Market, By Species
Veterinary Molecular Diagnostics Market, By End-User
Veterinary Molecular Diagnostics Market, By Region
The report covers:
Report scope:
The global Veterinary Molecular Diagnostics Market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include IDEXX Laboratories, Inc., ABAXIS, Inc., VCA, Inc., Neogen Corporation, Thermo Fisher Scientific, Inc., Zoetis, Inc., GE Healthcare, Heska Corporation, ID. Vet, Virbac, Veterinary Molecular Diagnostics, Inc., and AGFA Healthcare.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Microbiological Safety Cabinets market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Emergence of advanced veterinary molecular diagnostic tools over traditional diagnostic.
4.2.2. Growing focus on adopted pet’s and livestock’s health and nutrition
4.3. Restraints
4.3.1. High costs associated with these techniques
4.4. Opportunities
4.5. Challenges
5. Veterinary Molecular Diagnostics Market, By Product
5.1. Key Points
5.2. PCR kits
5.3. INAAT kits
5.4. Microarray kits
5.5. DNA sequencing kits
6. Veterinary Molecular Diagnostics Market, By Disease Type
6.1. Key Points
6.2. PCR kits
6.3. Anaplasma spp.
6.4. Ehrlichia spp.
6.5. New Castle Disease
6.6. Influenza
6.7. Porcine Reproductive & Respiratory Syndrome (PRRS
6.8. Others
7. Veterinary Molecular Diagnostics Market, By Species
7.1. Key Points
7.2. Livestock Animals
7.2.1. Aquatic
7.2.2. Bovine
7.2.3. Porcine
7.2.4. Ovine
7.2.5. Poultry
7.2.6. Equine
7.3. Companion Animals
7.3.1. Canine
7.3.2. Feline
7.3.3. Avian
8. Veterinary Molecular Diagnostics Market, By End-Use
8.1. Key Points
8.2. Veterinary Hospitals
8.3. Clinical Laboratories
8.4. Veterinary Research Institutes
9. Competitive Landscape
9.1. Introduction
9.2. Recent Developments
9.2.1. Mergers & Acquisitions
9.2.2. New Product Developments
9.2.3. Portfolio/Production Capacity Expansions
9.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.2.5. Others
10. Company Profile
10.1. bioMérieux SA
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. IDEXX Laboratories, Inc.
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Thermo Fisher Scientific Inc.
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Qiagen N.V.
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Neogen Corporation
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
Veterinary Molecular Diagnostics Market has been segmented as below:
Veterinary Molecular Diagnostics Market, By Product
Veterinary Molecular Diagnostics Market, By Disease Type
Veterinary Molecular Diagnostics Market, By Species
Veterinary Molecular Diagnostics Market, By End-User
Veterinary Molecular Diagnostics Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS